Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Veracyte, Inc. (VCYT) had Stock-Based Compensation of $26.85M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$150.32M |
|
$25.49M |
|
$41.77M |
|
$108.55M |
|
$127.34M |
|
$22.98M |
|
$3.54M |
|
$26.52M |
|
$26.52M |
|
$25.49M |
|
$25.49M |
|
$25.49M |
|
$25.49M |
|
$22.98M |
|
$27.09M |
|
79.97M |
|
82.06M |
|
$0.32 |
|
$0.31 |
|
| Balance Sheet Financials | |
$574.77M |
|
$21.93M |
|
$911.59M |
|
$1.49B |
|
$62.74M |
|
-- |
|
$35.23M |
|
$97.96M |
|
$1.39B |
|
$538.55M |
|
$1.39B |
|
80.36M |
|
| Cash Flow Statement Financials | |
$81.04M |
|
$-141.51M |
|
$-2.49M |
|
$364.23M |
|
$301.19M |
|
$-63.04M |
|
|
Stock-Based Compensation |
$26.85M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
72.21% |
|
15.29% |
|
15.29% |
|
-- |
|
17.64% |
|
16.96% |
|
$75.22M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.84 |
|
2.77 |
|
32.44 |
|
1.84% |
|
4.73% |
|
1.71% |
|
1.84% |
|
$17.28 |
|
$0.92 |
|
$0.99 |
|